FLML News Alert Flamel Technologies S.A. (FLML) 16.48 12/17/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Flamel Technologies S.A. (FLML) 16.48 $FLML

Flamel Technologies Transfers Intangible Property to Irish-Based Subsidiary in Global Reorganization
Marketwired - Tue Dec 16, 7:30AM CST
Flamel Technologies (NASDAQ: FLML) announced today that it is moving all intangible property from its French entity to its Irish-based entity as a part of a global reorganization. The intangible property includes patents on its drug delivery platform technologies, clinical data sets and other intangible assets related to its pipeline of proprietary products in development. Flamel's proprietary drug delivery platforms include its Micropump(R) (and its applications to the development of liquid formulations LiquiTime(R) and of abuse-deterrent formulations Trigger Lock(TM)) and Medusa(TM) platforms. We anticipate the transfer will result in a one-time tax payment of approximately $14 million to the French government.
FLML: 16.48 (+0.27)

Nasdaq makes annual changes to Biotechnology Index
Seeking Alpha - at Seeking Alpha - Mon Dec 15, 11:36AM CST

TTPH: 30.02 (+0.70), ZSPH: 44.19 (-2.83), AMRN: 1.03 (-0.02), OPHT: 45.94 (+0.36), AERI: 28.04 (-1.08), ASPX: 25.09 (+0.78), CNCE: 10.58 (+0.11), ICEL: 5.41 (+0.14), GWPH: 67.64 (-0.49), AUXL: 32.75 (-0.01), RTRX: 11.12 (+0.56), RCPT: 114.46 (-0.67), AAVL: 50.79 (-0.48), AKBA: 11.03 (+0.44), EXPR: 13.63 (+0.04), RARE: 40.65 (+0.89), RLYP: 31.59 (-1.40), PETX: 11.88 (-0.71), ENTA: 41.14 (-1.97), RDUS: 26.30 (+1.20), CARA: 9.54 (-0.19), FLML: 16.48 (+0.27), ALIM: 5.47 (+0.13), ANIP: 55.08 (+1.32), ICPT: 129.30 (-4.61), RVNC: 16.46 (+0.12), POZN: 9.03 (+0.10), FPRX: 21.92 (+0.07), ZFGN: 21.67 (-0.08), CRIS: 1.15 (-0.01), QLTI: 3.41 (-0.03), PCYC: 129.56 (+1.12), PTX: 9.20 (+0.06), CLDN: 17.76 (+0.03), RIGL: 2.12 (+0.01), HPTX: 21.60 (-0.06), AMPH: 11.28 (+0.25), INO: 8.34 (+0.08), VSAR: 19.17 (+0.11), FMI: 20.73 (-0.15), TBPH: 13.48 (-0.13), XLRN: 37.63 (-0.37), MGNX: 28.79 (-0.20), INSM: 13.70 (-0.13), ONTX: 3.94 (-0.12), ALDR: 24.79 (-0.77), SAGE: 37.66 (+3.29), KITE: 52.49 (-1.41), CGEN: 7.98 (-0.01), FOLD: 7.73 (-0.15), KPTI: 31.07 (-0.82)

Flamel Technologies to Be Included in NASDAQ Biotech Index
Marketwired - Mon Dec 15, 7:25AM CST
Flamel Technologies (NASDAQ: FLML) announced today that its common stock has been selected for inclusion in the NASDAQ Biotechnology Index (NBI), effective before market open on Monday, December 22, 2014. The NASDAQ Biotechnology Index was established in 1993, and is designed to track the performance of a set of securities listed on The NASDAQ Stock Market(R) (NASDAQ(R)) that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark (ICB). The NASDAQ Biotechnology Index is a modified market capitalization weighted index.
FLML: 16.48 (+0.27)

Annual Changes to the NASDAQ Biotechnology Index
GlobeNewswire - Mon Dec 15, 6:10AM CST
The NASDAQ OMX Group, Inc. (Nasdaq:NDAQ) today announced the results of the annual re-ranking of the NASDAQ Biotechnology Index (Nasdaq:NBI), which will become effective prior to market open on Monday, December 22, 2014.
TTPH: 30.02 (+0.70), ZSPH: 44.19 (-2.83), AMRN: 1.03 (-0.02), OPHT: 45.94 (+0.36), AERI: 28.04 (-1.08), ASPX: 25.09 (+0.78), CNCE: 10.58 (+0.11), ICEL: 5.41 (+0.14), GWPH: 67.64 (-0.49), AUXL: 32.75 (-0.01), RTRX: 11.12 (+0.56), RCPT: 114.46 (-0.67), AAVL: 50.79 (-0.48), AKBA: 11.03 (+0.44), EXPR: 13.63 (+0.04), RARE: 40.65 (+0.89), ZGNX: 1.11 (-0.03), RLYP: 31.59 (-1.40), PETX: 11.88 (-0.71), ENTA: 41.14 (-1.97), RDUS: 26.30 (+1.20), CARA: 9.54 (-0.19), FLML: 16.48 (+0.27), ALIM: 5.47 (+0.13), ANIP: 55.08 (+1.32), ICPT: 129.30 (-4.61), RVNC: 16.46 (+0.12), POZN: 9.03 (+0.10), NDAQ: 45.74 (-0.72), FPRX: 21.92 (+0.07), CRIS: 1.15 (-0.01), ZFGN: 21.67 (-0.08), QLTI: 3.41 (-0.03), PCYC: 129.56 (+1.12), PTX: 9.20 (+0.06), CLDN: 17.76 (+0.03), RIGL: 2.12 (+0.01), HPTX: 21.60 (-0.06), AMPH: 11.28 (+0.25), INO: 8.34 (+0.08), VSAR: 19.17 (+0.11), FMI: 20.73 (-0.15), TBPH: 13.48 (-0.13), XLRN: 37.63 (-0.37), MGNX: 28.79 (-0.20), INSM: 13.70 (-0.13), ONTX: 3.94 (-0.12), ALDR: 24.79 (-0.77), SAGE: 37.66 (+3.29), KITE: 52.49 (-1.41), CGEN: 7.98 (-0.01), FOLD: 7.73 (-0.15), KPTI: 31.07 (-0.82)

Flamel Technologies Has Returned 18.4% Since SmarTrend Recommendation (FLML)
Comtex SmarTrend(R) - Wed Dec 10, 9:23AM CST
SmarTrend identified an Uptrend for Flamel Technologies (NASDAQ:FLML) on November 25th, 2014 at $14.23. In approximately 2 weeks, Flamel Technologies has returned 18.43% as of today's recent price of $16.85.
FLML: 16.48 (+0.27)

Why Flamel Technologies (FLML) Could Be Positioned for a Surge? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Dec 04, 7:39AM CST
Positive earnings estimate revisions suggest that analysts are becoming more optimistic on Flamel Technologies’ earnings for the coming quarter and year.
FLML: 16.48 (+0.27)

Flamel clears resistance
Seeking Alpha - at Seeking Alpha - Wed Dec 03, 2:51PM CST

FLML: 16.48 (+0.27)

Flamel Technologies (FLML) in Focus: Stock Rises 8.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Dec 03, 7:37AM CST
Flamel Technologies SA (FLML) was a big mover last session, as the company saw its shares rise more than 8% on the day.
LCI: 42.70 (-1.35), FLML: 16.48 (+0.27), SCMP: 12.89 (+0.23), IG: 8.78 (+0.18)

Flamel Technologies Closes Sale of Development and Manufacturing Facility in Pessac, France to Recipharm AB
Marketwired - Mon Dec 01, 3:15PM CST
Flamel Technologies (NASDAQ: FLML) announced today that it has closed the sale of its development and manufacturing facility located in Pessac, France, to Recipharm AB that was announced on November 28, 2014. Under the agreement, Recipharm paid Flamel EUR 10.6 million and made an investment of EUR 10.5 million in Flamel's stock at a purchase price equal to the trailing 20-day average price.
FLML: 16.48 (+0.27)

Flamel Technologies plans divestiture of the Pessac facility
M2 - Mon Dec 01, 7:37AM CST
Flamel Technologies (NASDAQ:FLML) reported on Friday an agreement to sell its development and manufacturing facility located in Pessac, France for a purchase price of EUR10.6m before year end 2014.
FLML: 16.48 (+0.27)

3 Biotech Stocks With Jaw-Dropping Growth Potential in 2015
George Budwell, The Motley Fool - Motley Fool - Sat Nov 29, 1:01PM CST
The biotech industry has been absolutely soaring over the past two years, fueled by a rise in drug approvals, an merger-and-acquisition frenzy, and widespread reorganizations that have helped to mitigate the impact of the so-called "patent cliff."...
JNJ: 102.76 (-1.20), FLML: 16.48 (+0.27), GERN: 3.04 (+0.06), ICPT: 129.30 (-4.61), IBB: 293.67 (-3.99)

Flamel sells development & manufacturing facility to Swedish firm
Seeking Alpha - at Seeking Alpha - Fri Nov 28, 8:49AM CST

FLML: 16.48 (+0.27), GSK: 41.92 (+0.62)

Flamel Technologies Sells Development and Manufacturing Facility in Pessac, France to Recipharm AB
Marketwired - Fri Nov 28, 7:15AM CST
Flamel Technologies (NASDAQ: FLML) announced today that it has entered into an agreement to divest its development and manufacturing facility located in Pessac, France, to Recipharm AB. Under the agreement, Recipharm will pay Flamel EUR 10.6 million and make an investment of EUR 10.5 million in Flamel's stock upon the closing of deal at a purchase price equal to the trailing 20-day average price. This new partnership allows Flamel to retain access to the development and manufacturing capabilities of Pessac and gain the use of any of Recipharm's other facilities for the development or manufacture of their proprietary pipeline if needed. The Pessac facility is not currently used for the production of Flamel finished products and Flamel intends to continue to outsource to third party contract manufacturing companies like Recipharm.
FLML: 16.48 (+0.27)

Recipharm acquires Flamel Technologies facility in Pessac, France
M2 - Fri Nov 28, 4:36AM CST
Recipharm AB (STO: RECI), a CDMO (Contract Development and Manufacturing Organisation) in the pharmaceutical industry, announced on Thursday the signing of an agreement with Flamel Technologies SA (Nasdaq:FLML), a drug delivery company, under which Recipharm will purchase Flamel's development and manufacturing facility located in Pessac, France.
FLML: 16.48 (+0.27)

Flamel Technologies: A Turnaround Story With Lots Of Upside
Small Pharma Analyst - at Seeking Alpha - Fri Nov 21, 12:05PM CST

FLML: 16.48 (+0.27), CNCE: 10.58 (+0.11)

Comparing 3 Major Drug Delivery Companies
Joseph Cafariello - at Seeking Alpha - Mon Nov 17, 10:57AM CST

FLML: 16.48 (+0.27), PETS: 13.76 (+0.30), ALKS: 52.34 (-1.08)

Flamel Technologies (FLML) in Focus: Stock Rises 11% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 8:46AM CST
Flamel Technologies (FLML) was a big mover last session, with shares rising just over 11% on the day.
LCI: 42.70 (-1.35), FLML: 16.48 (+0.27), ADHD: 3.56 (+0.27), SCMP: 12.89 (+0.23)

Nasdaq stocks posting largest percentage increases
AP - Thu Nov 13, 5:05PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
ESCA: 13.78 (-0.14), IMDZ: 22.15 (+0.35), OLED: 25.59 (-0.22), FUEL: 15.03 (+0.06), CZR: 12.16 (-0.13), NTIC: 21.08 (-0.27), RESN: 8.59 (-0.31), OREX: 5.91 (-0.09), VBFC: 22.76 (+0.01), FLML: 16.48 (+0.27), ACHN: 12.92 (+0.20), RDI: 12.89 (+0.39), AMOT: 21.26 (-0.35), SUSQ: 12.89 (-0.09), RDIB: 12.88 (+0.52)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Thu Nov 13, 11:48AM CST

IMDZ: 22.15 (+0.35), VTNR: 3.21 (+0.16), CYBR: 37.27 (-0.17), LJPC: 15.38 (+1.28), ZAZA: 1.28 (+0.04), XPLR: 6.51 (+0.10), FUEL: 15.03 (+0.06), NADL: 1.44 (+0.08), DWA: 20.87 (+0.05), CZR: 12.16 (-0.13), RCAP: 10.90 (+0.44), AMTX: 4.98 (+0.32), FLML: 16.48 (+0.27), AMOT: 21.26 (-0.35), RVNC: 16.46 (+0.12), LOCM: 1.20 (+0.01), JGW: 9.33 (+0.04), ICLD: 2.78 (-0.29), VPCO: 1.27 (+0.06), CSH: 20.77 (+0.07)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 137

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 21

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading
Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 184

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 319

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 168

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 114

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 196

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 142

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
Alibaba Lawsuit Deadline Puts Disclosure Risk in Focus

Updated Category News Views 191

A calendar deadline is doing more work than any earnings headline for Alibaba shareholders this week. A securities class action notice says investors who bought or acquired Alibaba Group Holding Limited securities between May 23, 2024 and November 11, 2026 may seek appointment as lead plaintiff by January 19, 2027. That is a procedural milestone, not a verdict, and...

Continue Reading
Domino's Probe Puts Franchise Disclosure Under Lens

Updated Category News Views 139

A franchisee's shuttered stores can turn cheerful unit-growth talk into a nasty accounting of credibility, and that is the uncomfortable territory Domino's now occupies. Kahn Swick & Foti has opened an investigation into whether Domino's officers and directors breached fiduciary duties or violated state or federal law. That is not a finding of misconduct. It is a legal...

Continue Reading

Top 5 Most Recently Viewed Articles

Crest Auto Group Teams Up with Football Star Kevin Jennings

Updated Category News Views 228

Crest Auto Group Partners with Rising Star Kevin Jennings Crest Auto Group, a renowned automotive dealership with a strong legacy in the industry, is taking a giant leap forward by announcing its inaugural collegiate Name, Image, and Likeness (NIL) partnership with the exceptional Kevin Jennings. As a team captain and quarterback, Jennings hails from a community that...

Continue Reading
Carolwood Estates Celebrates a Stellar 2024 Year of Growth

Updated Category News Views 390

Carolwood Estates Unveils Its 2024 Annual Report In a remarkable demonstration of resilience and success, Carolwood Estates has released its 2024 Annual Report, shining a spotlight on a fabulous year filled with record-breaking accomplishments. Under the leadership of CEO Drew Fenton, the brokerage has made notable strides within the competitive landscape of luxury real...

Continue Reading
Savage Appoints Josh Anders as Strategic Chief Financial Officer

Updated Category News Views 896

Welcoming Josh Anders to Savage Leadership Savage is thrilled to announce the appointment of Josh Anders as the new Chief Financial Officer (CFO) of the company. With a strong background in finance and a wealth of experience in various financial leadership roles, Anders is set to join the ranks of Savage’s effective global supply chain team. Experience and Leadership...

Continue Reading
John Hardin Enhances UBS Private Wealth Management Team in Miami

Updated Category News Views 91

UBS Welcomes New Financial Advisor in Miami UBS Private Wealth Management is making significant strides in enhancing its service offerings in South Florida with the inclusion of John Hardin as a Financial Advisor. This strategic move aims to bolster the firm's presence in Miami, strengthening relationships with clients and expanding the wealth management team. An...

Continue Reading
Investors Urged to Act by October: Hims & Hers Health Update

Updated Category News Views 270

Attention Hims & Hers Health Investors Investors holding shares in Hims & Hers Health, Inc. are urged to stay vigilant regarding significant developments affecting their investments. The Company, often simply referred to as Hims, is currently facing securities class action lawsuits filed by investors who believe they suffered financial losses during a specified period....

Continue Reading